Skip to main content
Clinical Trials/DRKS00006162
DRKS00006162
Completed
未知

Early Palliative Care – Health services research and implementation of sustainable changes - EVI

Klinik für Pallliativmedizin, Universitätsklinikum Freiburg0 sites592 target enrollmentMay 19, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
C34
Sponsor
Klinik für Pallliativmedizin, Universitätsklinikum Freiburg
Enrollment
592
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 19, 2014
End Date
July 21, 2017
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Klinik für Pallliativmedizin, Universitätsklinikum Freiburg

Eligibility Criteria

Inclusion Criteria

  • 1\.Initial diagnosis of a metastatic, incurable cancer (ICD 10 C 1\-80 plus ICD 10 C 78\-79\) occurred within the last eight weeks, particularly:
  • \-non\-small cell lung cancer (NSCLC) without epidermal growth factor (EFGR) mutations: met. NSCLC Stage IV – ICD C34\.\[01239] \+ metastasis code or C34\.8 (multiple subdomains) \+ possibly M8012/3 (large cell carcinoma)
  • \-met. esophageal carcinoma Stage IV – ICD C15\.\[123459] \+ metastasis code or C15\.8 (multiple subdomains) \+ possibly M8070/3 (squamous cell carcinoma)
  • \-met. stomach carcinoma Stage IV \- ICD C16\.\[01234569] \+ metastasis code or C16\.8 (multiple subdomains) \+ possibly M8145/3 (adenocarcinoma, diffuse)
  • \-non\-endocrine pancreas carcinoma Stage IV \- ICD C25\.\[012379] \+ metastasis code or C25\.8 (multiple subdomains) \+ possibly M8971/3 (pancreas blastoma)
  • \-center\-specific tumor entities
  • 2\.Age \= 18 years
  • 3\.Ability to understand written and verbal questions in German
  • 4\.Willingness to participate in the study
  • 5\.Informed consent

Exclusion Criteria

  • 1\.Other hemato\-oncological disease (e.g. leukemia)
  • 2\.Dementia
  • 3\.Psychosis / delirium
  • 4\.Major depression

Outcomes

Primary Outcomes

Not specified

Similar Trials